Filter
2052
Filtered Results: 2052
Text search:
Drug
Safety
Monitoring
Programme
Featured
Recommendations
228
New Publications
668
Language
Document type
No document type
1250
Guidelines
299
Studies & Reports
245
Manuals
112
Strategic & Response Plan
92
Training Material
21
Fact sheets
18
Situation Updates
8
Infographics
4
Resource Platforms
2
Online Courses
1
Countries / Regions
India
131
Kenya
72
Global
59
South Africa
57
Nigeria
55
Uganda
50
Sierra Leone
44
Tanzania
41
Western and Central Europe
41
Nepal
39
Ghana
38
Ethiopia
35
Zambia
35
Myanmar / Burma
35
Liberia
30
Malawi
30
Bangladesh
28
Africa
28
Namibia
27
Eastern Europe
18
South–East Asia Region
17
Lesotho
16
Zimbabwe
14
Cambodia
14
Botswana
13
Latin America and the Carribbean
13
Asia
13
Rwanda
12
Philippines
11
Syria
11
Indonesia
10
Ukraine
10
Congo, Democratic Republic of
9
Russia
8
Cameroon
7
Eswatini/ Swaziland
7
Senegal
6
Pakistan
6
East and Southern Africa
6
West and Central Africa
6
Eastern Europe and Central Asia
6
Tajikistan
6
Burkina Faso
5
South Sudan
5
Thailand
5
Middle East and North Africa
5
Western Pacific Region
5
Albania
5
Mozambique
4
Laos
4
Guinea
3
Iraq
3
Germany
3
Georgia
3
USA
2
Haiti
2
Somalia
2
Afghanistan
2
China
2
Sudan
2
Brazil
2
Sri Lanka
2
Bhutan
2
United Kingdom
2
Jordan
1
Lebanon
1
Turkey
1
Gambia
1
Ireland
1
Singapore
1
Benin
1
Central African Republic
1
Peru
1
North Macedonia
1
Serbia
1
Colombia
1
Honduras
1
El Salvador
1
Libya
1
Angola
1
Madagascar
1
Yemen
1
Paraguay
1
Poland
1
Southern Africa
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Lithuania
1
Moldova
1
Uzbekistan
1
Kyrgyzstan
1
Vietnam
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
838
Clinical Guidelines
214
Public Health
135
Women & Child Health
94
Key Resources
69
Pharmacy & Technologies
36
Capacity Building
28
Toolboxes
HIV
234
TB
173
AMR
145
Mental Health
127
Pharmacy
74
COVID-19
73
Caregiver
49
Rapid Response
47
NTDs
45
NCDs
41
Ebola
34
Planetary Health
32
Conflict
27
Global Health Education
26
Disability
22
Refugee
21
Cholera
9
Polio
9
Natural Hazards
9
Health Financing Toolbox
9
Specific Hazards
8
Zika
5
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome ...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
The document "Global Report on Diabetes" by the World Health Organization (WHO) provides an in-depth analysis of diabetes as a global health challenge. It covers the rising prevalence of the disease, the associated risk factors, and the increasing burden on healthcare systems, particularly in low- a...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f...
Alcohol use is deeply embedded in the social landscape of many societies, and some 2300 million people drink alcoholic beverages in most parts of the world. At the same time, more than half of the global population aged 15 years and older reported having abstained from drinking alcohol during the pr...
Alcohol consumption is deeply embedded in the social landscape of many societies. Several major factors have an impact on levels and patterns of alcohol consumption in populations – such as historical trends in alcohol consumption, the availability of alcohol, culture, economic status and trends i...
This document highlights landmarks and key milestones in the development and implementation of the global agenda for noncommunicable diseases (NCDs) over the last two decades. It summarizes where the world was in 2000, where it is in 2022, and where the world wants to be in terms of NCD prevention a...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi...
Providing quality, stigma-free services is essential to equitable health care for all and achieving global HIV goals and broader Sustainable Development Goals related to health. Every person has the right to the highest attainable standard of physical and mental health. Countries have a legal obliga...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
